Over 43% of menopausal women have obesity, and about 20% of women gain 10 pounds or more during the menopause transition, which can also increase the risk for insulin resistance
Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin
GLP-1 receptor agonists are evidence-based medications that support blood sugar regulation, appetite control, and metabolic function
LCLT has been suggested to support muscle gain and healthy body composition
[DOI] [PubMed] [Google Scholar] (80).Stano P
watch now Compass Point's Max Reale talks the impact of a possible FDA ban on compounded GLP-1 offerings Max Reale, Compass Point head of policy research, joins 'Closing Bell Overtime' to talk the current state of the weight-loss drug space and the impact of a possible compounded GLP-1 ban